Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -25.00% | -.--% | +200.00% |
Apr. 22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
Apr. 12 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.6 million in funding | CI |
Sales 2022 | 1.07 1.48 | Sales 2023 | 1.03 1.42 | Capitalization | 2.87M 3.96M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.78M | Net income 2023 | -2M -2.76M | EV / Sales 2022 | 8,069,982 x |
Net Debt 2022 | 1.01M 1.39M | Net Debt 2023 | 2.46M 3.39M | EV / Sales 2023 | 5,181,017 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-1.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | -25.00% | ||
Current month | -40.00% | ||
1 month | -40.00% | ||
6 months | +200.00% | ||
Current year | +200.00% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
James Duncan
BRD | Director/Board Member | - | 23-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.015 | -25.00% | 105,118 |
24-04-29 | 0.02 | +33.33% | 13,742 |
24-04-26 | 0.015 | -.--% | 94,000 |
24-04-25 | 0.015 | -.--% | 2,060 |
24-04-24 | 0.015 | -.--% | 39,005 |
Delayed Quote Toronto S.E., April 30, 2024 at 09:38 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+200.00% | 3.18M | |
-14.25% | 85.35B | |
+14.46% | 81.95B | |
+9.37% | 28.99B | |
-11.40% | 16.98B | |
-0.36% | 16.85B | |
+0.22% | 15.35B | |
+4.32% | 12.42B | |
-2.34% | 11.88B | |
+32.69% | 12.19B |
- Stock Market
- Equities
- IBO Stock